Mass Tort Lead Generation in 2025: Why NEC Claims Are a Strong Investment

Introduction Necrotizing enterocolitis (NEC), a devastating intestinal disease affecting premature infants, has sparked one of the most compelling mass tort litigations of 2025. With over 700 lawsuits pending against Mead Johnson (Enfamil) and Abbott Laboratories (Similac) in federal multidistrict litigation (MDL 3026), and landmark plaintiff verdicts totaling $555 million, NEC claims are reshaping the legal […]